| Item type |
デフォルトアイテムタイプ（フル）(1) |
| 公開日 |
2020-05-29 |
| タイトル |
|
|
タイトル |
Appropriate radiation dose for symptomatic relief and local control in patients with adult T cell leukemia/lymphoma |
|
言語 |
en |
| 作成者 |
Maemoto, Hitoshi
Ariga, Takuro
Nakachi, Sawada
Toita, Takafumi
Hashimoto, Seiji
Heianna, Joichi
Shiina, Hideki
Kusada, Takeaki
Makino, Wataru
Kakinohana, Yasumasa
Miyagi, Takuya
Yamamoto, Yuichi
Morishima, Satoko
Masuzaki, Hiroaki
Murayama, Sadayuki
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利情報 |
|
|
言語 |
en |
|
権利情報 |
Creative Commons Attribution-NonCommercial 4.0 |
| 権利情報 |
|
|
言語 |
en |
|
権利情報Resource |
https://creativecommons.org/licenses/by-nc/4.0/ |
|
権利情報 |
https://creativecommons.org/licenses/by-nc/4.0/ |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
radiotherapy |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
adult T-cell leukemia/lymphoma |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
human T-cell leukemia virus type 1 |
| 主題 |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
palliative radiotherapy |
| 内容記述 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Adult T-cell leukemia/lymphoma (ATL) is an aggressive peripheral T-cell neoplasm that occurs only in patients with human T-cell leukemia virus type 1. No large study or randomized trial investigating radiotherapy (RT) for ATL has been performed. We retrospectively reviewed 55 courses of RT for 41 consecutive patients with ATL who underwent RT between 2000 and 2016 at our institutions. The results showed that RT for local ATL lesions can achieve symptomatic improvement in 92% of cases. Local remission, either complete remission (CR) or partial response (PR), was achieved in 100% of the patients (CR: 89%, PR: 11%) with ≥40 Gy irradiation. CR or PR was achieved in 71% (CR: 29%, PR: 43%) with 30–39 Gy and in 73% (CR: 6.7%, PR: 67%) with ≤29 Gy irradiation. The mean total radiation dose in the CR and PR groups differed significantly (38 vs 25 Gy, P = 0.0002). The maximum acute toxicity was Grade 0–2 in all patients, except for one patient experienced Grade 3 radiation dermatitis. In-field relapses occurred in 36% of patients, and the frequency of in-field relapses was 11%, 30% and 71% among those who achieved CR, PR and SD, respectively. All 9 patients who received total skin irradiation experienced cutaneous relapses, with a median of 63 days (range, 7–210 days). Almost all (39 of 41) patients with ATL experienced out-of-field progression after RT. In conclusion, RT was confirmed to be effective and safe for palliative treatment of local ATL lesions. |
| 内容記述 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
論文 |
| 出版者 |
|
|
出版者 |
Oxford University Press |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 識別子 |
|
|
識別子 |
http://hdl.handle.net/20.500.12000/45947 |
|
識別子タイプ |
HDL |
| 関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1093/jrr/rry068 |
| 関連情報 |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
https://doi.org/10.1093/jrr/rry068 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
0449-3060 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1349-9157 |
| 収録物名 |
|
|
収録物名 |
Journal of Radiation Research |
|
言語 |
en |
| 書誌情報 |
巻 60,
号 1,
p. 98-108,
発行日 2019-01
|
rry068.pdf
